-

Henry Schein Medical Enhances Access to Ansell Isolation Gowns Amid COVID-19, Helping to Improve the Safety of Front-Line Health Care Professionals

AlphaTec® Model 214 Gowns Feature Advanced Chemical Protection with DuPont™ Tyvek® Material, Rear-Fastening Closures, Concealed Cuffs, and Bound Seams

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc., today announced the availability of Ansell Healthcare Product’s AlphaTec® Model 214 gowns to practitioners in North America. The availability of these gowns enables Henry Schein to help deliver greater access to Ansell’s non-surgical isolation gowns, which feature durable DuPont™ Tyvek® 1222A fabric, and advanced chemical protection, helping to enhance the safety of front-line health care workers amid COVID-19.

By distributing AlphaTec® Model 214 gowns, Henry Schein is fulfilling its commitment of procuring PPE to help ensure its customers – physician offices, hospitals, and other health care institutions – have the supplies they need to focus on delivering patient care, as outlined in the company’s “Rebuilding Together” initiative. Similarly, the company is helping to fulfill the mission of Ansell’s recently launched #NetworkofHeroes program, which offers support to non-PPE manufacturers, as well as DuPont’s program, #TyvekTogether, which partners with companies, such as Ansell, to help increase the supply of Tyvek® garments to the marketplace.

“Henry Schein and Ansell share a commitment to help enhance the accessibility of reliable and durable gowns as well as the safety of front-line health care professionals,” said Brad Connett, President, U.S. Medical Group, Henry Schein, Inc. “We are pleased to partner with Ansell and to leverage our strong distribution and supply chain network to increase the availability of its AlphaTec gowns featuring DuPont™ Tyvek® 1222A fabric. Amid the soaring demand for personal protective equipment, partnering with Ansell can help us deliver greater access to gowns our customers can rely on to help them safely deliver care to patients.”

The long-sleeved, water-resistant non-surgical gowns feature rear-fastening closures that tie at the neck and waist; concealed, non-latex elasticated cuffs; and bound seams. Available in two sizes – M/L, XL/2XL – the gowns also feature advanced barrier protection with DuPont™ Tyvek® 1222A fabric, which is intended for protective apparel, such as coveralls, hoods, sleeves, and non-surgical isolation gowns.

“We are thrilled to partner with Henry Schein, whose extensive physician customer base can help us ensure greater reach, and ultimately improved safety,” said Paul Bryce, Vice President & General Manager, Ansell Chemical Solutions SBU. “Together, we are committed to helping ensure the safety of our front-line heroes.”

To order AlphaTec® Model 214 gowns, please contact a Henry Schein Medical sales representative at 1-800-372-4346 or to learn more, please visit www.henryscheinmedical.com.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can help provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries. The Company's sales from continuing operations reached $10.0 billion in 2019, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.

About Ansell Limited

Ansell is a world leader in providing superior health and safety protection solutions that enhance human well-being. The world’s need for better protection never stops, so Ansell is constantly researching, developing and investing to manufacture and distribute cutting edge product innovation and technology, marketed under well-known brands that customers trust.

Operating in two main business segments, Industrial and Healthcare, Ansell is the market leader that continues to grow, employing 12,000 people worldwide. With operations in North America, Latin America/Caribbean, EMEA and Asia Pacific, customers in more than 100 countries around the world trust Ansell and its protection solutions.

Information on Ansell and its products can be found at www.ansell.com. #AnsellProtects

Contacts

Ann Marie Gothard
Vice President, Corporate Media Relations
Annmarie.gothard@henryschein.com
(631) 390-8169

Henry Schein, Inc.

NASDAQ:HSIC

Release Versions

Contacts

Ann Marie Gothard
Vice President, Corporate Media Relations
Annmarie.gothard@henryschein.com
(631) 390-8169

More News From Henry Schein, Inc.

Henry Schein Expands Partnership with vVARDIS

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the expansion of its agreement with vVARDIS, which grants the Company exclusive U.S. distribution rights for the drill-free Curodont™ Repair Fluoride Plus (“Curodont”) product across all dental market segments, effective January 1, 2026. The strategic expansion broadens Henry Schein’s previous exclusivity with the Swiss company, which was announced in 2024 for Dental Service Organizations (DSOs). Starting next ye...

Henry Schein to Participate in Upcoming Investor Conference in December

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., (Nasdaq: HSIC) the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in December: Piper Sandler’s Healthcare Conference at the Lotte New York Palace Hotel, New York, on December 2, 2025, at 9:00 a.m. Eastern time. Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcas...

Henry Schein Reports Record Third Quarter 2025 Financial Results and Raises Full Year Non-GAAP EPS Guidance

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the third quarter ended September 27, 2025. “We are pleased with our financial results for the third quarter, with sales growth accelerating in each of our reportable segments including solid market share gains in our distribution businesses as we are once again focused on driving growth n...
Back to Newsroom